Published on: April 12, 2012
by Michael Roizen, M.D., and Mehmet Oz, M.D. for The Post and Courier
D-3, the disease-blocking vitamin that keeps you healthy, maybe not wealthy, but definitely wise.
D-3’s immune-regulating powers can D-feat brain-destroying amyloid tangles that contribute to Alzheimer’s mental deterioration. While we await human trials of bexarotene (the skin-cancer drug that Case Western University researchers discovered can activate removal of Alzheimer’s plaques in mice), we YOU Docs hope you keep “Prevent D” in your brain-boosting playbook.
Eating fresh vegetables and fruit, 100 percent whole grains and lean proteins (especially omega-3/DHA-rich fish, such as salmon and trout) are great ways to get heart-protecting, brain-enhancing, cancer-fighting vitamins. But that may not be enough. Half of adults are D-ficient.
If you’re typical, you’re probably sun D-prived — spending 90 percent of your time indoors, and when you’re outside, you slather on high-SPF sunscreen. Add to that other D-blockers, such as having dark skin, being overweight, having diabetes or kidney disease, PLUS not eating D-rich foods, and YOU definitely need a D-3 supplement.
To make sure you get enough:
Spend 15-30 minutes a day from 10 a.m. to 3 p.m. (using a sunscreen with an SPF of 8 or less) in the sun.
Take in 1,000 IU of D-3 a day from food or a supplement; 2,000 IU max without talking with your doc.
Mehmet Oz, M.D. is host of “The Dr. Oz Show,” and Mike Roizen, M.D. is Chief Medical Officer at the Cleveland Clinic Wellness Institute.
Our event with Dr. Wendy Suzuki explaining how higher levels of physical fitness are associated with better brain structure and higher cognitive function. Highlights video.
Our event with Dr. Wendy Suzuki explaining how higher levels of physical fitness are associated with better brain structure and higher cognitive function. Full video.
Two blood markers, phosphorylated tau 217 (p-tau217) and phosphorylated tau 181 (p-tau181), showed strong diagnostic performances for Alzheimer’s disease and discriminated Alzheimer’s from frontotemporal lobar denervation (FTLD) syndromes and normal cognition, a retrospective study...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.